1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Pure Global Cannabis Inc.

Pure Global Cannabis Inc.

PRCNF
Pure Global Cannabis Inc.US flagOther OTC
0.00
USD
- -
- -
1,616.00Market Cap
Pure Global Cannabis Inc.
PRCNF
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2017
2018
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
Revenue per Share
-0.04
-0.03
-0.04
-0.19
-0.16
-0.05
-0.02
-0.02
-0.23
-0.07
Basic EPS, GAAP
-0.05
-0.03
-0.02
-0.13
-0.05
-0.01
-0.01
-0.02
-0.18
-0.11
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.04
-0.05
-0.07
-0.86
-0.97
-0.29
-0.05
-0.04
-0.25
-0.23
Book Value per Share
0.04
0.09
0.01
-0.07
-0.22
-0.11
-0.01
- -
0.09
0.02
Tangible Book Value per Share
5
9
15
2
2
7
63
63
104
155
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2,012.71
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
Depreciation Expense
- -
- -
-1
- -
- -
- -
-1
-1
-23
-11
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-880.4
Profit Margin (%)
- -
1
- -
- -
- -
-1
- -
- -
6
-5
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
7
6
LT Debt
- -
1
- -
- -
- -
-1
- -
- -
9
4
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Aug'17
Jun'19
Sep'19
ST Debt
- -
5
5
LT Borrowings
- -
6
6
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
23
159
159
Market Capitalization
- -
17
23

Working Capital

FRC

•

in mil. unless spec.
Aug'17
Jun'19
Sep'19
Total Current Assets
- -
5
2
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
- -
1
- -
Inventories
- -
2
2
Total Current Liabilities
- -
7
8
Payables & Accruals
- -
2
3
ST Debt
- -
5
5
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
551.77%
2,633.05%
Free Cash Flow
- -
450.74%
1,526.57%
Net Income, GAAP
- -
519.97%
2,363.28%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -
2019
- -
1
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
-0.01
- -
-0.02
2018
- -
- -
-0.03
-0.13
-0.23
2019
-0.02
-0.02
-0.02
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
Similar Companies
WEED, Inc. (BUDZ)
Nanexa AB (publ) (NANEXA.ST)
RedHill Biopharma Ltd. (RDHL)
Radient Technologies Inc. (RTI.V)
Yuhan Corporation (000100.KS)
Innova Captab Limited (INNOVACAP.NS)
Business
Pure Global Cannabis Inc. (PRCNF) is a Canada-based life sciences cannabis company that manufactures branded and white label cannabis and cannabidiol (CBD) consumer products; bulk dried flower; full spectrum concentrates; and pre-formulated active ingredients for consumer packaged goods manufacturers. The company operates its business-to-business brand PureCanna Solutions, which provides high-margin bulk cannabis extracts, bulk CBD sales, white label products, and manufacturing services; it also offers dried flowers, cannabis oils, soft gels and capsules, clones, and sprays for medical, pharmaceutical, wellness, health and beauty, natural health, food and beverage, and recreational legal markets under brands including PureSinse, SPARK Medical Cannabis clinics, and The Great Canadian Hemp Company. Headquartered in Toronto, Ontario, at 418-2095 Lake Shore Boulevard West, the company focuses on vertically integrated operations primarily in Canada with interests in global medical and recreational cannabis markets. Recent developments include a 2020 reverse takeover transaction with PureSinse Inc., which expanded its production capabilities, and the closure of an acquisition of The Great Canadian Hemp Company (GCHC) paired with a global distribution deal to broaden market reach. In 2020, the company entered a binding agreement to acquire a 60% stake in Avicanna's Colombian subsidiary Savita Nativa, S.A.S., with an option for full ownership, signaling strategic expansion into Latin America. These moves follow earlier receivership proceedings in 2020 involving certain subsidiaries and assets, after which the company restructured under new ownership transactions.